IARS2 mutations lead to Leigh syndrome with a combined oxidative phosphorylation deficiency.
IARS2
Leigh syndrome
Mitochondrial disease
OXPHOS
Journal
Orphanet journal of rare diseases
ISSN: 1750-1172
Titre abrégé: Orphanet J Rare Dis
Pays: England
ID NLM: 101266602
Informations de publication
Date de publication:
21 Aug 2024
21 Aug 2024
Historique:
received:
19
01
2024
accepted:
06
08
2024
medline:
22
8
2024
pubmed:
22
8
2024
entrez:
21
8
2024
Statut:
epublish
Résumé
Leigh syndrome (LS) is a common mitochondrial disease caused by mutations in both mitochondrial and nuclear genes. Isoleucyl-tRNA synthetase 2 (IARS2) encodes mitochondrial isoleucine-tRNA synthetase, and variants in IARS2 have been reported to cause LS. However, the pathogenic mechanism of IARS2 variants is still unclear. Two unrelated patients, a 4-year-old boy and a 5-year-old boy diagnosed with LS, were recruited, and detailed clinical data were collected. The DNA of the patients and their parents was isolated from the peripheral blood for the identification of pathogenic variants using next-generation sequencing and Sanger sequencing. The ClustalW program, allele frequency analysis databases (gnomAD and ExAc), and pathogenicity prediction databases (Clinvar, Mutation Taster and PolyPhen2) were used to predict the conservation and pathogenicity of the variants. The gene expression level, oxygen consumption rate (OCR), respiratory chain complex activity, cellular adenosine triphosphate (ATP) production, mitochondrial membrane potential (MMP) and mitochondrial reactive oxygen species (ROS) levels were measured in patient-derived lymphocytes and IARS2-knockdown HEK293T cells to evaluate the pathogenicity of the variants. We reported 2 unrelated Chinese patients manifested with LS who carried biallelic IARS2 variants (c.1_390del and c.2450G > A from a 4-year-old boy, and c.2090G > A and c.2122G > A from a 5-year-old boy), of which c.1_390del and c.2090G > A were novel. Functional studies revealed that the patient-derived lymphocytes carrying c.1_390del and c.2450G > A variants exhibited impaired mitochondrial function due to severe mitochondrial complexes I and III deficiencies, which was also found in IARS2-knockdown HEK293T cells. The compensatory experiments in vitro cell models confirmed the pathogenicity of IARS2 variants since re-expression of wild-type IARS2 rather than mutant IARS2 could rescue complexes I and III deficiency, oxygen consumption, and cellular ATP content in IARS2 knockdown cells. Our results not only expand the gene mutation spectrum of LS, but also reveal for the first time the pathogenic mechanism of IARS2 variants due to a combined deficiency of mitochondrial complexes I and III, which is helpful for the clinical diagnosis of IARS2 mutation-related diseases.
Sections du résumé
BACKGROUND
BACKGROUND
Leigh syndrome (LS) is a common mitochondrial disease caused by mutations in both mitochondrial and nuclear genes. Isoleucyl-tRNA synthetase 2 (IARS2) encodes mitochondrial isoleucine-tRNA synthetase, and variants in IARS2 have been reported to cause LS. However, the pathogenic mechanism of IARS2 variants is still unclear.
METHODS
METHODS
Two unrelated patients, a 4-year-old boy and a 5-year-old boy diagnosed with LS, were recruited, and detailed clinical data were collected. The DNA of the patients and their parents was isolated from the peripheral blood for the identification of pathogenic variants using next-generation sequencing and Sanger sequencing. The ClustalW program, allele frequency analysis databases (gnomAD and ExAc), and pathogenicity prediction databases (Clinvar, Mutation Taster and PolyPhen2) were used to predict the conservation and pathogenicity of the variants. The gene expression level, oxygen consumption rate (OCR), respiratory chain complex activity, cellular adenosine triphosphate (ATP) production, mitochondrial membrane potential (MMP) and mitochondrial reactive oxygen species (ROS) levels were measured in patient-derived lymphocytes and IARS2-knockdown HEK293T cells to evaluate the pathogenicity of the variants.
RESULTS
RESULTS
We reported 2 unrelated Chinese patients manifested with LS who carried biallelic IARS2 variants (c.1_390del and c.2450G > A from a 4-year-old boy, and c.2090G > A and c.2122G > A from a 5-year-old boy), of which c.1_390del and c.2090G > A were novel. Functional studies revealed that the patient-derived lymphocytes carrying c.1_390del and c.2450G > A variants exhibited impaired mitochondrial function due to severe mitochondrial complexes I and III deficiencies, which was also found in IARS2-knockdown HEK293T cells. The compensatory experiments in vitro cell models confirmed the pathogenicity of IARS2 variants since re-expression of wild-type IARS2 rather than mutant IARS2 could rescue complexes I and III deficiency, oxygen consumption, and cellular ATP content in IARS2 knockdown cells.
CONCLUSION
CONCLUSIONS
Our results not only expand the gene mutation spectrum of LS, but also reveal for the first time the pathogenic mechanism of IARS2 variants due to a combined deficiency of mitochondrial complexes I and III, which is helpful for the clinical diagnosis of IARS2 mutation-related diseases.
Identifiants
pubmed: 39169373
doi: 10.1186/s13023-024-03310-x
pii: 10.1186/s13023-024-03310-x
doi:
Substances chimiques
Amino Acyl-tRNA Synthetases
EC 6.1.1.-
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
305Subventions
Organisme : the National Natural Science Foundation of China-excellent young scientists fund
ID : 82222043
Organisme : the Natural Science Foundation of China
ID : U22A20342
Organisme : Natural Science Foundation of China
ID : 82302636
Organisme : Zhejiang Provincial leading talents program Foundation
ID : 2024C03152
Organisme : Zhejiang Provincial Natural Science Foundation
ID : LQ23H200001
Organisme : Scientific Research Fund of Zhejiang Provincial Education Department
ID : Y202249698
Organisme : the Science and Technology Bureau of Wenzhou
ID : Y2023089
Informations de copyright
© 2024. The Author(s).
Références
Stenton SL, Zou Y, Cheng H, Liu Z, Wang J, Shen D, Jin H, Ding C, Tang X, Sun S. Leigh syndrome: a study of 209 patients at the Beijing children’s hospital. Ann Neurol. 2022;91(4):466–82.
pubmed: 35094435
Leigh D. Subacute necrotizing encephalomyelopathy in an infant. J Neurol Neurosurg Psychiatry. 1951;14(3):216.
pubmed: 14874135
pmcid: 499520
Yahya V, Spagnolo F, Di Maggio G, Leopizzi E, De Marco P, Fortunato F, Comi GP, Rini A, Monfrini E, Di Fonzo A. Juvenile-onset dystonia with spasticity in Leigh syndrome caused by a novel NDUFA10 variant. Parkinsonism Relat Disord. 2022;104:85–7.
pubmed: 36270260
Lim AZ, Ng YS, Blain A, Jiminez-Moreno C, Alston CL, Nesbitt V, Simmons L, Santra S, Wassmer E, Blakely EL. Natural history of Leigh syndrome: a study of disease burden and progression. Ann Neurol. 2022;91(1):117–30.
pubmed: 34716721
Kistol D, Tsygankova P, Krylova T, Bychkov I, Itkis Y, Nikolaeva E, Mikhailova S, Sumina M, Pechatnikova N, Kurbatov S. Leigh syndrome: spectrum of molecular defects and clinical features in Russia. Int J Mol Sci. 2023;24(2):1597.
pubmed: 36675121
pmcid: 9865855
of Neurology SG, of, Neurology SC, Board E. Expert consensus on the diagnosis and treatment of Leigh syndrome (2023). Zhonghua er ke za zhi = Chinese J Pediatrics. 2023;61(12):1077–1085.
Fernandez-Vizarra E, Zeviani M. Mitochondrial disorders of the OXPHOS system. FEBS Lett. 2021;595(8):1062–106.
pubmed: 33159691
Chang X, Wu Y, Zhou J, Meng H, Zhang W, Guo J. A meta-analysis and systematic review of Leigh syndrome: clinical manifestations, respiratory chain enzyme complex deficiency, and gene mutations. Medicine. 2020;99(5).
Rahman S. Leigh syndrome. Handbook of clinical neurology. Volume 194. Elsevier; 2023. pp. 43–63.
Zhou X, Lou X, Zhou Y, Xie Y, Han X, Dong Q, Ying X, Laurentinah MR, Zhang L, Chen Z. Novel biallelic mutations in TMEM126B cause splicing defects and lead to Leigh-Like syndrome with severe complex I deficiency. J Hum Genet. 2023;68(4):239–46.
pubmed: 36482121
Lim SC, Smith KR, Stroud DA, Compton AG, Tucker EJ, Dasvarma A, Gandolfo LC, Marum JE, McKenzie M, Peters HL. A founder mutation in PET100 causes isolated complex IV deficiency in Lebanese individuals with Leigh syndrome. Am J Hum Genet. 2014;94(2):209–22.
pubmed: 24462369
pmcid: 3928654
Bonnefond L, Fender A, Rudinger-Thirion J, Giegé R, Florentz C, Sissler M. Toward the full set of human mitochondrial aminoacyl-tRNA synthetases: characterization of AspRS and TyrRS. Biochemistry. 2005;44(12):4805–16.
pubmed: 15779907
Antonellis A, Green ED. The role of aminoacyl-tRNA synthetases in genetic diseases. Annu Rev Genomics Hum Genet. 2008;9:87–107.
pubmed: 18767960
Meyer-Schuman R, Antonellis A. Emerging mechanisms of aminoacyl-tRNA synthetase mutations in recessive and dominant human disease. Hum Mol Genet. 2017;26(R2):R114–27.
pubmed: 28633377
pmcid: 5886470
Florentz C, Sohm B, Tryoen-Toth P, Pütz J, Sissler M. Human mitochondrial tRNAs in health and disease. Cell Mol Life Sci CMLS. 2003;60:1356–75.
pubmed: 12943225
Schwartzentruber J, Buhas D, Majewski J, Sasarman F, Papillon-Cavanagh S, Thiffaut I, Sheldon KM, Massicotte C, Patry L, Simon M. Mutation in the Nuclear‐Encoded mitochondrial Isoleucyl–t RNA synthetase IARS2 in patients with cataracts, growth hormone Deficiency with short stature, partial Sensorineural Deafness, and Peripheral Neuropathy or with Leigh Syndrome. Hum Mutat. 2014;35(11):1285–9.
pubmed: 25130867
Takezawa Y, Fujie H, Kikuchi A, Niihori T, Funayama R, Shirota M, Nakayama K, Aoki Y, Sasaki M, Kure S. Novel IARS2 mutations in Japanese siblings with CAGSSS, Leigh, and West syndrome. Brain Develop. 2018;40(10):934–8.
Moosa S, Haagerup A, Gregersen PA, Petersen KK, Altmüller J, Thiele H, Nürnberg P, Cho TJ, Kim OH, Nishimura G. Confirmation of CAGSSS syndrome as a distinct entity in a Danish patient with a novel homozygous mutation in IARS2. Am J Med Genet Part A. 2017;173(4):1102–8.
pubmed: 28328135
Gong Y, Lan XP, Guo S. IARS2-related disease manifesting as sideroblastic anemia and hypoparathyroidism: a case report. Front Pead. 2023;10:1080664.
Upadia J, Li Y, Walano N, Deputy S, Gajewski K, Andersson HC. Genotype–phenotype correlation in IARS2-related diseases: a case report and review of literature. Clin Case Rep. 2022;10(2):e05401.
pubmed: 35228874
pmcid: 8867157
Barcia G, Pandithan D, Ruzzenente B, Assouline Z, Pennisi A, Ormieres C, Besmond C, Roux C-J, Boddaert N, Desguerre I. Biallelic IARS2 mutations presenting as sideroblastic anemia. Haematologica. 2021;106(4):1220.
pubmed: 33327715
pmcid: 8018106
Roux C-J, Barcia G, Schiff M, Sissler M, Levy R, Dangouloff-Ros V, Desguerre I, Edvardson S, Elpeleg O, Rötig A. Phenotypic diversity of brain MRI patterns in mitochondrial aminoacyl-tRNA synthetase mutations. Mol Genet Metab. 2021;133(2):222–9.
pubmed: 33972171
Lee JS, Kim MJ, Kim SY, Lim BC, Kim KJ, Choi M, Seong M-W, Chae J-H. Clinical and genetic characteristics of Korean patients with IARS2-related disorders. J Genetic Med. 2019;16(2):55–61.
Calvo SE, Compton AG, Hershman SG, Lim SC, Lieber DS, Tucker EJ, Laskowski A, Garone C, Liu S, Jaffe DB. Molecular diagnosis of infantile mitochondrial disease with targeted next-generation sequencing. Sci Transl Med. 2012;4(118):ra118110–118110.
Thompson JD, Gibson TJ, Higgins DG. Multiple sequence alignment using ClustalW and ClustalX. Curr Protocols Bioinf. 2003(1):2.3. 1–2.3. 22.
Gudmundsson S, Singer-Berk M, Watts NA, Phu W, Goodrich JK, Solomonson M, Consortium GAD, Rehm HL. MacArthur DG, O’Donnell‐Luria A: variant interpretation using population databases: lessons from gnomAD. Hum Mutat. 2022;43(8):1012–30.
pubmed: 34859531
Sherry ST, Ward M-H, Kholodov M, Baker J, Phan L, Smigielski EM, Sirotkin K. dbSNP: the NCBI database of genetic variation. Nucleic Acids Res. 2001;29(1):308–11.
pubmed: 11125122
pmcid: 29783
Kobayashi Y, Yang S, Nykamp K, Garcia J, Lincoln SE, Topper SE. Pathogenic variant burden in the ExAC database: an empirical approach to evaluating population data for clinical variant interpretation. Genome Med. 2017;9(1):1–14.
Landrum MJ, Lee JM, Benson M, Brown GR, Chao C, Chitipiralla S, Gu B, Hart J, Hoffman D, Jang W. ClinVar: improving access to variant interpretations and supporting evidence. Nucleic Acids Res. 2018;46(D1):D1062–7.
pubmed: 29165669
Schwarz JM, Rödelsperger C, Schuelke M, Seelow D. MutationTaster evaluates disease-causing potential of sequence alterations. Nat Methods. 2010;7(8):575–6.
pubmed: 20676075
Adzhubei I, Jordan DM, Sunyaev SR. Predicting functional effect of human missense mutations using PolyPhen-2. Curr Protocols Hum Genet. 2013;76(1):7. 21–27.20. 41.
Zhou X, Lou X, Zhou Y, Xie Y, Han X, Dong Q, Ying X, Laurentinah MR, Zhang L, Chen Z. Novel biallelic mutations in TMEM126B cause splicing defects and lead to Leigh-Like syndrome with severe complex I deficiency. J Hum Genet. 2022:1–8.
Wittig I, Braun H-P, Schägger H. Blue native PAGE. Nat Protoc. 2006;1(1):418–28.
pubmed: 17406264
Vona B, Maroofian R, Bellacchio E, Najafi M, Thompson K, Alahmad A, He L, Ahangari N, Rad A, Shahrokhzadeh S. Expanding the clinical phenotype of IARS2-related mitochondrial disease. BMC Med Genet. 2018;19:1–16.